Facts & Data

Facts and data to help you understand brain and eye disease.

What can we help you find?

More Filters
    Clear all
  • Fact Sheet

    Macular Degeneration: Frequently Asked Questions

    Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina. Read the answers to the most frequently asked questions about this eye disease.

    March 1, 2019
  • Fact Sheet

    Glaucoma: Facts & Figures

    More than 3 million Americans are living with glaucoma, and 2.7 million of whom-aged 40 and older-are affected by its most common form, open-angle glaucoma. Get the facts about glaucoma.

    June 27, 2019
  • Fact Sheet

    Financial Aid for Glaucoma Medications

    Learn about financial aid resources that may be available to help cover the costs of your glaucoma prescription medications.

    June 18, 2019
  • Fact Sheet

    Alzheimer’s Disease: Facts & Figures

    It is estimated that nearly 500,000 new cases of Alzheimer's disease will be diagnosed this year in the United States. Every 3 seconds, someone in the world develops dementia. Get the facts about Alzheimer's disease—the most common form of dementia.

    March 5, 2019
  • Fact Sheet

    Clinical Trial Information for Glaucoma

    It can take many years for a potential treatment for glaucoma to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    March 14, 2019
  • Fact Sheet

    Clinical Trial Information for Macular Degeneration

    It can take many years for a potential treatment for macular degeneration to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    April 23, 2019
  • Fact Sheet

    Clinical Trial Information for Alzheimer's Disease

    It can take many years for a potential treatment for Alzheimer's disease to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    February 1, 2019
    • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Please enter your first name.
    Please enter your last name.
    Keep me informed about: *
    Please select at least one.
    You must select at least one disease category.

    Join us in the fight to end brain and eye disease

    • 1 in 16 Americans over age 40 has either Alzheimer's, macular degeneration, or glaucoma.

    • BrightFocus has funded more than $220 million in groundbreaking research to eradicate brain and eye disease. 

    • BrightFocus makes innovative science possible around the world—1,625 research projects involving more than 5,363 scientists in 25 countries.

    • You can make a difference. 
      Support BrightFocus-funded research to end brain and eye diseases in our lifetime.

      Give Now